Enoxolone
CAS No. 471-53-4
Enoxolone ( Arthrodont; Biosone; Enoxolone; α-Glycyrrhetinic Acid; GM 1658; NSC 35347; PO 12; STX 352 )
产品货号. M14567 CAS No. 471-53-4
Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption.
纯度: >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
500MG | ¥348 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Enoxolone
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption.
-
产品描述Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure. Trials were halted in the U.S., but the drug is used in various countries.
-
同义词Arthrodont; Biosone; Enoxolone; α-Glycyrrhetinic Acid; GM 1658; NSC 35347; PO 12; STX 352
-
通路Metabolic Enzyme/Protease
-
靶点Dehydrogenase
-
受体DHO
-
研究领域Other Indications
-
适应症——
化学信息
-
CAS Number471-53-4
-
分子量470.68
-
分子式C30H46O4
-
纯度>98%(HPLC)
-
溶解度DMSO: 94 mg/mL (199.71 mM)
-
SMILESCC(C)([C@](CC[C@@]([C@@]1(CC[C@]2(CC[C@](C(O)=O)(C[C@]2(C1=C3)[H])C)C)C)4C)5[H])[C@@H](O)CC[C@]5(C)[C@@]4([H])C3=O
-
化学全称(2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Boldt J, et al. Expert Opin PharmacOthers. 2007, 8(13):2135-47.
产品手册
关联产品
-
Dovitinib Dilactic A...
Dovitinib Dilactic acid (TKI258 Dilactic acid) is the Dilactic acid of Dovitinib, which is a multitargeted RTK inhibitor.
-
Taraxerone
Taraxerone has allelopathic and antifungal effects.Taraxerone prevents catalase, superoxide dismutase, and reduces glutathione concentrations from the decrease induced by ethanol administration with the concentration dependent manner.
-
Carbenoxolone
Carbenoxolone is an inhibitor of 11β-HSD and gap junction connexin channels. Carbenoxolone inhibits macrophage migration into atria and prevents the development of fatty liver disease.